TYRA
TYRA
NASDAQ · Biotechnology

Tyra Biosciences Inc

$21.10
+0.21 (+1.01%)
As of Nov 7, 1:47 AM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target -11.2% upside
Low Target $15.89
Average Target $18.74
High Target $31.24
Current Price $21.10
Current
$21.10
Target
$18.74
$15.89 $18.74 avg $31.24
Scenario Analysis
Bear Case
$15.89
-24.7%
Low target
Base Case
$18.74
-11.2%
Avg target
Bull Case
$31.24
+48.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$40.65
-48.1% from high
52-Week Low
$13.35
+58.1% from low
Target vs 52W High
$18.74
-53.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%